← 返回

装载磁性纳米颗粒的 CAR-T 细胞实现可控靶向抑制炎性细胞因子释放并转换肿瘤细胞死亡机制

英文原题:Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.

查看英文原题

Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.

PubMed 2025/01/05(内容时间) MedComm (2020) Q1 · IF 14.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

嵌合抗原受体(CAR)T细胞治疗血液系统恶性肿瘤显示出很大潜力,但其治疗实体瘤的成功受到肿瘤运输和浸润有限、实体瘤癌症特异性抗原稀少等因素制约。

因此,在目标部位富集肿瘤抗原特异性CAR-T 细胞,对于提高疗效、降低全身性靶上非肿瘤毒性至关重要。本研究以超顺磁性氧化铁纳米颗粒(SPION)对人CAR-T 细胞进行功能化改造,使其可受磁场控制并实现部位靶向。负载SPION的CAR-T 细胞仍能特异性杀伤表达CAR靶抗原硫酸软骨素蛋白聚糖(CSPG4)的黑色素瘤细胞。

重要的是,SPION抑制了负载CAR-T 细胞的细胞因子释放,并使肿瘤细胞死亡表型由细胞焦亡转为细胞凋亡。此外,在动态流动模型中,负载SPION的CAR-T 细胞可通过外部磁场富集,并能够通过MRI检测。这些结果表明,SPION功能化后CAR-T 细胞仍保留裂解性细胞毒能力,为未来针对实体瘤、减少全身不良反应的部位特异性免疫疗法奠定了基础。

展开英文摘要原文

Therapies against hematological malignancies using chimeric antigen receptors (CAR)-T cells have shown great potential; however, therapeutic success in solid tumors has been constrained due to limited tumor trafficking and infiltration, as well as the scarcity of cancer-specific solid tumor antigens.

Therefore, the enrichment of tumor-antigen specific CAR-T cells in the desired region is critical for improving therapy efficacy and reducing systemic on-target/off-tumor side effects.

Here, we functionalized human CAR-T cells with superparamagnetic iron oxide nanoparticles (SPIONs), making them magnetically controllable for site-directed targeting. SPION-loaded CAR-T cells maintained their specific cytolytic capacity against melanoma cells expressing the CAR-specific antigen chondroitin sulfate proteoglycan (CSPG4).

Importantly, SPIONs suppressed cytokine release in the loaded CAR-T cells, shifting the cell death phenotype in the tumor cells from pyroptosis to apoptosis.

Furthermore, SPION-loaded CAR-T cells could be enriched in a dynamic flow model through an external magnetic field and be detected in MRI. These results demonstrate that lytic cytotoxicity is retained after SPION-functionalization and provides a basis for future site-specific immunotherapies against solid tumors with reduced systemic adverse side effects.

论文信息

作者
Pfister F、Carnell LR、Löffler L、Boosz P、Schaft N、Dörrie J、Stein R、Lenz M
单位
Department of Otorhinolaryngology Head and Neck Surgery Section of Experimental Oncology and Nanomedicine (SEON) Else Kröner-Fresenius-Stiftung Professorship Universitätsklinikum Erlangen Erlangen Germany.Germany
期刊
MedComm2025 Jan
原文标识
PubMed 39764559 · DOI 10.1002/mco2.70039